TRCT
CDMO

Tower Research Capital (TRC)’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Tower Research Capital (TRC)’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,739
Closed -$157K – 6019
2024
Q4 		$157K Buy
12,739
+5,352
+72% +$61.3K ﹤0.01% 1870
2024
Q3 		$84.1K Sell
7,387
-4,624
-38% -$46.4K ﹤0.01% 2357
2024
Q2 		$85.8K Buy
12,011
+10,187
+558% +$77.9K ﹤0.01% 2687
2024
Q1 		$12.2K Sell
1,824
-2,596
-59% -$17.9K ﹤0.01% 3499
2023
Q4 		$28.7K Buy
4,420
+1,001
+29% +$6.45K ﹤0.01% 3450
2023
Q3 		$32.3K Sell
3,419
-2,690
-44% -$32.4K ﹤0.01% 2960
2023
Q2 		$85.3K Buy
6,109
+3,300
+117% +$56.3K ﹤0.01% 2145
2023
Q1 		$52K Sell
2,809
-2,296
-45% -$37.7K ﹤0.01% 2465
2022
Q4 		$70K Buy
5,105
+1,327
+35% +$20.3K ﹤0.01% 2116
2022
Q3 		$72K Sell
3,778
-8,627
-70% -$157K ﹤0.01% 2852
2022
Q2 		$189K Buy
12,405
+10,734
+642% +$159K ﹤0.01% 1808
2022
Q1 		$34K Sell
1,671
-4,953
-75% -$101K ﹤0.01% 3044
2021
Q4 		$193K Sell
6,624
-5,201
-44% -$149K ﹤0.01% 1802
2021
Q3 		$255K Buy
11,825
+9,409
+389% +$227K 0.01% 1582
2021
Q2 		$62K Sell
2,416
-2,495
-51% -$53.3K ﹤0.01% 2846
2021
Q1 		$90K Sell
4,911
-3,114
-39% -$51.7K ﹤0.01% 2671
2020
Q4 		$92K Sell
8,025
-52,681
-87% -$482K ﹤0.01% 2429
2020
Q3 		$463K Buy
60,706
+48,612
+402% +$368K 0.01% 1765
2020
Q2 		$79K Buy
+12,094
New +$67.5K ﹤0.01% 2664
2019
Q4 		– Sell
-5,313
Closed -$29K – 4523
2019
Q3 		$29K Sell
5,313
-112
-2% -$695 ﹤0.01% 2219
2019
Q2 		$31K Sell
5,425
-15,266
-74% -$62.9K ﹤0.01% 1889
2019
Q1 		$88K Buy
20,691
+19,804
+2,233% +$80.8K 0.01% 1490
2018
Q4 		$4K Buy
+887
New +$4.63K ﹤0.01% 3086
2018
Q1 		– Sell
-2,841
Closed -$11K – 3950
2017
Q4 		$11K Buy
2,841
+2,803
+7,376% +$12K ﹤0.01% 2517
2017
Q3 		$0 Buy
+38
New +$143 ﹤0.01% 4220
2017
Q1 		– Sell
-9,223
Closed -$20K – 4063
2016
Q4 		$20K Buy
9,223
+8,628
+1,450% +$20.2K ﹤0.01% 2160
2016
Q3 		$2K Sell
595
-6,704
-92% -$18K ﹤0.01% 3157
2016
Q2 		$19K Buy
7,299
+1,877
+35% +$5.23K ﹤0.01% 2287
2016
Q1 		$16K Buy
5,422
+4,079
+304% +$21.8K ﹤0.01% 1524
2015
Q4 		$11K Buy
+1,343
New +$10.8K ﹤0.01% 2040
2015
Q3 		– Sell
-727
Closed -$7K – 4913
2015
Q2 		$7K Buy
727
+214
+42% +$2.06K ﹤0.01% 3020
2015
Q1 		$5K Buy
+513
New +$4.94K ﹤0.01% 3281
2014
Q4 		– Sell
-10,988
Closed -$104K – 4800
2014
Q3 		$104K Buy
+10,988
New +$123K 0.01% 898
2014
Q2 		– Sell
-1,853
Closed -$24K – 4737
2014
Q1 		$24K Buy
+1,853
New +$24.4K ﹤0.01% 1721
2013
Q3 		– Sell
-1,361
Closed -$12K – 4904
2013
Q2 		$12K Buy
+1,361
New +$14.3K ﹤0.01% 2213

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Tower Research Capital (TRC)'s CDMO Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 12,739 shares — an estimated $157K sold.

Tower Research Capital (TRC) first reported a position in CDMO in Q2 2013 and held it in 35 quarters. The position peaked at $463K in Q3 2020. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 12,739 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $157K.
  • Tower Research Capital (TRC) first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 35 quarters.
  • Tower Research Capital (TRC)'s Avid Bioservices, Inc. Common Stock position peaked at $463K in Q3 2020.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.